慢性心理应激对放疗后肿瘤免疫微环境的影响及其机制研究

基本信息
批准号:81602732
项目类别:青年科学基金项目
资助金额:17.00
负责人:邓窈窕
学科分类:
依托单位:四川大学
批准年份:2016
结题年份:2019
起止时间:2017-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:姜愚,刘杰,张杰,黄伯彦,莫泽明,郑博
关键词:
肿瘤免疫微环境慢性心理应激放射治疗PD1/PDL1
结项摘要

Radiation therapy is one of the main therapeutic strategies for patients with cancers. Unfortunately, immunosuppression signaling pathways such as the PD-1/PD-L1 axis has largely restrained the effect of radiotherapy. It is found that cancer patients are frequently under a chronic stress status, which could elevate levels of stress-related hormones like norepinephrine (NE). Studies have found that beta-blocker use is associated with improved survival outcomes in cancer patients treated with definitive radiation therapy and its mechanisms have yet to be elucidated. In our previous study, it was observed that NE could induce the expression of HIF-1α by activating the beta-adrenergic receptor, thus facilitating the downstream PD-1/PD-L1 axis. The PD-L1/PD-1 axis has been characterized as a potent inhibitor of T cell mediated specific adaptive immunity, particularly through inhibition of effector T cell function. Therefore, we speculate that under the state of chronic stress in vivo, NE could suppress the function of the immune system through the β-AR---HIF-1α---PD-1/ PD-L1 signal pathway. On the contrary, beta-blocker could block this process and improve the efficacy of anti-tumor immunity after radiotherapy. In this project, we plan to build tumor-bearing mice models to mimic the status of high levels of NE in cancer patients, to explore the effects and the underlying mechanisms of chronic stress on the tumor immune microenvironment after radiotherapy. So far as we know, there is no literature reported regarding how chronic stress could attenuate the anti-tumor immunity after radiotherapy from this perspective.

放射治疗是恶性肿瘤的重要治疗策略之一,然而以PD-1/PD-L1为代表的免疫抑制通路在很大程度上降低了放疗的疗效。肿瘤患者常处于慢性心理应激状态,致使体内以去甲肾上腺素(NE)为代表的压力相关激素水平升高。研究表明,β肾上腺素受体(β-AR)抑制剂可延长放疗的肿瘤患者的生存,然而机制不明。我们前期的研究发现,NE可通过激活β-AR上调乏氧诱导因子HIF-1α,促进其下游PD-1/PD-L1的表达。而PD-1/PD-L1通路的激活可抑制T细胞介导的特异性免疫应答。因此,我们推测,在慢性应激状态下,NE可通过β-AR---HIF-1α---PD-1/PD-L1通路促进放疗后免疫抑制;而β-AR拮抗剂可阻断这一过程,改善放疗后的抗肿瘤免疫反应。本项目拟模拟肿瘤患者所处的“慢性应激”状态构建荷瘤小鼠模型,探讨慢性应激对对放疗后肿瘤免疫微环境的影响及可能的的机制。据我们所知,目前国内外尚无类似报道。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

论大数据环境对情报学发展的影响

论大数据环境对情报学发展的影响

DOI:
发表时间:2017
2

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
3

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
4

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

DOI:
发表时间:
5

中国参与全球价值链的环境效应分析

中国参与全球价值链的环境效应分析

DOI:10.12062/cpre.20181019
发表时间:2019

邓窈窕的其他基金

相似国自然基金

1

低分割放疗对肿瘤免疫微环境的影响及免疫调节作用研究

批准号:81201752
批准年份:2012
负责人:王辛
学科分类:H1816
资助金额:23.00
项目类别:青年科学基金项目
2

慢性应激下肿瘤细胞来源的外泌体活化肿瘤微环境中的CAFs介导宫颈癌放疗抵抗的机制研究

批准号:81872460
批准年份:2018
负责人:杨姗姗
学科分类:H1821
资助金额:53.00
项目类别:面上项目
3

针刺对慢性应激抑郁大鼠脑细胞微环境的影响

批准号:81373729
批准年份:2013
负责人:图娅
学科分类:H3118
资助金额:68.00
项目类别:面上项目
4

良性心理应激抑制肿瘤作用及其免疫调控机制:基于丰富生存环境小鼠肿瘤模型的研究

批准号:81201823
批准年份:2012
负责人:甘愉
学科分类:H1818
资助金额:23.00
项目类别:青年科学基金项目